Moderna

Moderna is a biotechnology company known for its pioneering work in messenger RNA (mRNA) technology, particularly for its COVID-19 vaccine. Founded in 2010, it has rapidly gained prominence in the pharmaceutical industry, especially during the global pandemic. In recent financial reports, Moderna indicated a significant decline in revenue from its COVID-19 vaccine as demand decreases, leading to a reported loss of $1.12 billion for the fourth quarter. The company plans to diversify its portfolio by developing vaccines for other diseases, including influenza and cancer, and anticipates launching ten new products within the next three years.